Efficacy and safety of tenecteplase in acombination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction - The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators (Lancet, 2001)